Rotella Capital Management, Inc. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 117 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$91,000
-34.1%
10,360
-48.4%
0.08%
-45.5%
Q3 2014$138,000
+29.0%
20,060
-1.6%
0.14%
+59.3%
Q2 2014$107,000
+87.7%
20,376
+80.8%
0.09%
-19.5%
Q4 2013$57,000
-6.6%
11,272
-8.0%
0.11%
-41.8%
Q2 2013$61,00012,2550.19%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders